University of Wisconsin–Madison Medical College of Wisconsin

Pharmacotherapy Update

 

It’s challenging to keep informed of new developments in medications and their uses. WMJ’s Pharmacotherapy Update aims to provide detailed information about current, cutting-edge topics in the pharmacy world.

Read  more

Pharmacotherapy Update 1: Aducanumab

Aducanumab was approved on June 7, 2021 by the US Food and Drug Administration (FDA) using the accelerated approval pathway. Under this approval category, a drug must be used for a serious condition that fills an unmet medical need. The outcomes in the study are based on surrogate endpoints thought to predict clinical benefit but are not themselves a measure of clinical benefit.

Published online April 2, 2022. 

 

Share WMJ